Bloomage Biotechnology Corp. Ltd. is a leading player in the chemicals industry in China, with a strong focus on manufacturing and selling products made from hyaluronic acid sodium (HA). The company has a risk rating score of 40.7, indicating a severe risk assessment. Bloomage Biotechnology Corp. Ltd. is known for its commitment to ESG practices, particularly in the areas of sustainability and governance. The company operates in two segments, offering a range of HA raw materials and end products, including medical skin care products and beauty devices. With a significant portion of revenue coming from China, Bloomage Biotechnology Corp. Ltd. continues to be a key player in the industry.